Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity
<p>Abstract</p> <p>Background</p> <p>Bone metastases are a common cause of skeletal morbidity in patients with advanced cancer. The pattern of skeletal morbidity is complex, and the number of skeletal complications is influenced by the duration of survival. Because many...
Main Authors: | Smith Matthew R, Lipton Allan, Cook Richard J, Major Pierre P, Terpos Evangelos, Coleman Robert E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-08-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/272 |
Similar Items
-
Bone targeted therapies for the prevention of skeletal morbidity in men with prostate
by: Philip J Saylor
Published: (2014-06-01) -
Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
by: Tanya B Dorff, et al.
Published: (2018-01-01) -
Bone disease in haemoglobin disorders
by: Ersi Voskaridou, et al.
Published: (2013-03-01) -
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy
by: Antonio Laghezza, et al.
Published: (2020-06-01) -
The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma
by: Nikolaos Giannakoulas, et al.
Published: (2021-04-01)